EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access

Sex Hormone-Binding Globulin and Risk of Coronary Heart Disease in Men and Women

Jie Li iD, Lingling Zheng, Kei Hang Katie Chan, Xia Zou, Jihui Zhang iD, Jundong Liu, Qingwei Zhong, Tracy E Madsen, Wen-Chih Wu iD, JoAnn E Manson, Xueqing Yu, Simin Liu iD

Clinical Chemistry · 03.04.2023 · 69 (4) · 374-385

DOI: 10.1093/clinchem/hvac209 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Clinical Chemistry, online erschienen am 25.01.2023. Verfasst von Jie Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Global Health Research Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China. Hauptthemen laut MEDLINE: Coronary Disease, Myocardial Infarction. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council, NIEHS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The role of sex hormone-binding globulin (SHBG) levels in clinical risk stratification and intervention for coronary heart disease (CHD) remains uncertain. We aimed to examine whether circulating levels of SHBG are predictive of CHD risk in men and women.

Methods

We investigated the association between SHBG and the risk of incident CHD in 128 322 men and 135 103 women free of CHD at baseline in the prospective United Kingdom Biobank (UKB) cohort. The unconfounded associations were estimated using Mendelian randomization (MR) analysis. We further conducted a meta-analysis to integrate currently available prospective evidence. CHD events included nonfatal and fatal myocardial infarction and coronary revascularization.

Results

In the UKB, during a median of 11.7 follow-up years, 10 405 men and 4512 women developed CHD. Serum levels of SHBG were monotonically associated with a decreased risk of CHD in both men (adjusted hazard ratio [HR] per log nmol/L increase in SHBG: 0.88 [0.83–0.94]) and women (HR: 0.89 [0.83–0.96]). MR-based analyses suggested causality and a dose-response relationship of SHBG with CHD risk. A cumulative meta-analysis including 216 417 men and 138 282 women from 11 studies showed that higher levels of SHBG were prospectively associated with decreased CHD risk in men comparing the highest with the lowest quartile: pooled relative risk (RR) 0.81 (0.74–0.89) and women (pooled RR: 0.86 [0.78–0.94]).

Conclusions

Higher circulating SHBG levels were directly and independently predictive of lower CHD risk in both men and women. The utility of SHBG for CHD risk stratification and prediction warrants further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary DiseaseMyocardial InfarctionHumansProspective StudiesSex Hormone-Binding GlobulinRiskRisk Factors

Stichwörter der Autor:innen

Mendelian randomization analysisSHBGcoronary heart diseaseendogenousmenwomen

Substanzen

Sex Hormone-Binding Globulin

Autor:innen und Institutionen

  • Global Health Research Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • The Second School of Clinical Medicine, Southern Medical University, Guangzhou 510280, China.
  • School of Medicine, South China University of Technology, Guangzhou 510006, China.
  • Department of Epidemiology and Center for Global Cardiometabolic Health, School of Public Health, Brown University, Providence, RI, USA.
  • Departments of Biomedical Sciences and Electrical Engineering, City University of Hong Kong, Hong Kong SAR, China.
  • Guangdong Mental Health Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

ORCID-Profile: Jie Li, Jihui Zhang, Wen-Chih Wu, Simin Liu

Förderung

  • Medical Research Council
  • NIEHS NIH HHS
  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • National Natural Science Foundation of China
  • National Institutes of Health
  • Guangdong-Hong Kong Joint Laboratory on Immunological and Genetic Kidney Diseases

Zitieren

APA

Li, J., Zheng, L., Chan, K. H. K., Zou, X., Zhang, J., Liu, J., Zhong, Q., Madsen, T. E., Wu, W. C., Manson, J. E., Yu, X., & Liu, S. (2023). Sex Hormone-Binding Globulin and Risk of Coronary Heart Disease in Men and Women. Clinical Chemistry, 69(4), 374-385. https://doi.org/10.1093/clinchem/hvac209

Vancouver

Li J, Zheng L, Chan KHK, Zou X, Zhang J, Liu J, et al. Sex Hormone-Binding Globulin and Risk of Coronary Heart Disease in Men and Women. Clinical Chemistry. 2023;69(4):374-385. doi:10.1093/clinchem/hvac209

BibTeX
@article{Li2023,
  author = {Li, Jie and Zheng, Lingling and Chan, Kei Hang Katie and Zou, Xia and Zhang, Jihui and Liu, Jundong and Zhong, Qingwei and Madsen, Tracy E and Wu, Wen-Chih and Manson, JoAnn E and Yu, Xueqing and Liu, Simin},
  title = {Sex Hormone-Binding Globulin and Risk of Coronary Heart Disease in Men and Women},
  journal = {Clinical Chemistry},
  year = {2023},
  volume = {69},
  number = {4},
  pages = {374--385},
  doi = {10.1093/clinchem/hvac209}
}
Kostenlos starten →